Analysts think GCAN stock price could decrease by -100%
Jun 14, 2024, 6:30 AM
0.00%
What does GCAN do
The Greater Cannabis Co., Inc., headquartered in Baltimore, Maryland, focuses on developing cannabis-based treatments for neuropsychiatric disorders and other medical conditions through clinical trials. The company, which went public in 2018, advances its research and commercial interests through direct investments, joint ventures, licensing, acquisitions, and innovative drug delivery technologies like a dissolvable intra-oral patch.
2 analysts think GCAN stock price will decrease by -100.00%. The current median analyst target is $0 compared to a current stock price of $0.00. The lowest analysts target is $0.00 and the highest analyst target is $0.00.
📡️ N/A
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.